Mountain View, Calif., October 25, 2018 — IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in upcoming investor conferences.

IRIDEX’s management is scheduled to present at the Stephens NY Investment Conference on Wednesday, November 7th, 2018 at 4:00 pm Eastern Time.

IRIDEX’s management is scheduled to present at the Stifel Healthcare Conference in New York City on Tuesday, November 13th, 2018 at 3:30 pm Eastern Time.

Interested parties may access a live and archived webcast of both presentations from the Investor Events section of the Company’s website at www.IRIDEX.com.

About IRIDEX

IRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX’s products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. IRIDEX is headquartered in Mountain View, CA.

Investor Relations Contact:

Lynn Pieper Lewis or Leigh Salvo
415.937.5404
investors@iridex.com

Media Contact:

Jamie Hall
Pascale Communications, LLC.
724.417.0167
pr@iridex.com